132 related articles for article (PubMed ID: 20450899)
21. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.
Boorjian SA; Karnes RJ; Crispen PL; Rangel LJ; Bergstralh EJ; Sebo TJ; Blute ML
J Urol; 2009 Jan; 181(1):95-104; discussion 104. PubMed ID: 19012937
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
23. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
Wang L; McDonnell SK; Slusser JP; Hebbring SJ; Cunningham JM; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Res; 2007 Apr; 67(7):2944-50. PubMed ID: 17409399
[TBL] [Abstract][Full Text] [Related]
24. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
[TBL] [Abstract][Full Text] [Related]
25. The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population.
Wokołorczyk D; Gliniewicz B; Stojewski M; Sikorski A; Złowocka E; Debniak T; Jakubowska A; Górski B; van de Wetering T; Narod SA; Lubiński J; Cybulski C
Eur J Cancer Prev; 2010 Mar; 19(2):167-71. PubMed ID: 19952762
[TBL] [Abstract][Full Text] [Related]
26. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
27. Changing nature of high risk patients undergoing radical prostatectomy.
Kane CJ; Presti JC; Amling CL; Aronson WJ; Terris MK; Freedland SJ;
J Urol; 2007 Jan; 177(1):113-7. PubMed ID: 17162017
[TBL] [Abstract][Full Text] [Related]
28. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
[TBL] [Abstract][Full Text] [Related]
30. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility.
Chung S; Nakagawa H; Uemura M; Piao L; Ashikawa K; Hosono N; Takata R; Akamatsu S; Kawaguchi T; Morizono T; Tsunoda T; Daigo Y; Matsuda K; Kamatani N; Nakamura Y; Kubo M
Cancer Sci; 2011 Jan; 102(1):245-52. PubMed ID: 20874843
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
[TBL] [Abstract][Full Text] [Related]
32. PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness.
Loeb S; Sutherland DE; D'Amico AV; Roehl KA; Catalona WJ
Urology; 2008 Nov; 72(5):1116-20; discussion 1120. PubMed ID: 18571700
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer risk variants are not associated with disease progression.
Szulkin R; Holmberg E; Stattin P; Xu J; Zheng S; Palmgren J; Grönberg H; Wiklund F
Prostate; 2012 Jan; 72(1):30-9. PubMed ID: 21520160
[TBL] [Abstract][Full Text] [Related]
34. HNF1B polymorphism associated with development of prostate cancer in Korean patients.
Kim HJ; Bae JS; Lee J; Chang IH; Kim KD; Shin HD; Han JH; Lee SY; Kim W; Myung SC
Urology; 2011 Oct; 78(4):969.e1-6. PubMed ID: 21982019
[TBL] [Abstract][Full Text] [Related]
35. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
[TBL] [Abstract][Full Text] [Related]
36. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of genome-wide and replication association studies on prostate cancer.
Liu H; Wang B; Han C
Prostate; 2011 Feb; 71(2):209-24. PubMed ID: 20690139
[TBL] [Abstract][Full Text] [Related]
38. Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.
Ho CK; Halley L; Wei J; Habib FK
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):365-8. PubMed ID: 22733159
[TBL] [Abstract][Full Text] [Related]
39. A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians.
Oskina NA; Boyarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
Urol Oncol; 2014 Jan; 32(1):37.e7-12. PubMed ID: 23628314
[TBL] [Abstract][Full Text] [Related]
40. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
